(Q39853590)

15 September 2017

Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features (English)

1 reference

15 September 2017

0 references

Patricia A. Marken

1

1 reference

PMC publication ID

181142

15 September 2017

J Stuart Munro

series ordinal

2

1 reference

15 September 2017

1 December 2000

1 reference

Primary Care Companion to the Journal of Clinical Psychiatry

15 September 2017

1 reference

15 September 2017

2

1 reference

15 September 2017

6

1 reference

15 September 2017

205-210

1 reference

Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Selective serotonin-reuptake inhibitors: an update

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Depression and increased risk of mortality in the nursing home patient

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Synaptic effects of antidepressants

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Pharmacokinetics of selective serotonin reuptake inhibitors: clinical relevance

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

St. John's wort and antidepressant drug interactions in the elderly.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Depressive symptoms and physical decline in community-dwelling older persons

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Inhibitors of imipramine metabolism by human liver microsomes

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Minor and major depression and the risk of death in older persons

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Fluoxetine and sertraline dosages in major depression.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181142

A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide

20 August 2018

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers

1 reference

12 December 2020

Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide*

1 reference

12 December 2020

The effect of sertraline on the pharmacokinetics of desipramine and imipramine

1 reference

12 December 2020

Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice

1 reference

12 December 2020

Increased carbamazepine plasma concentrations after fluoxetine coadministration

1 reference

12 December 2020

Gender, depression, and one-year prognosis after myocardial infarction

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro

1 reference

12 December 2020

Citalopram: interaction studies with levomepromazine, imipramine, and lithium

1 reference

12 December 2020

SSRIs and St.John's Wort: possible toxicity?

1 reference

12 December 2020

Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients

1 reference

12 December 2020

Possible interaction between sertraline and tranylcypromine

1 reference

12 December 2020

Effect of sertraline on plasma nortriptyline levels in depressed elderly

1 reference

12 December 2020

Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications

1 reference

12 December 2020

A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

1 reference

12 December 2020

Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants

1 reference

12 December 2020

Pharmacokinetics of paroxetine in patients with cirrhosis

1 reference

12 December 2020

Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide

1 reference

12 December 2020

Identifiers

DOI

10.4088/PCC.V02N0602

1 reference

15 September 2017

1 reference

PMC publication ID

181142

15 September 2017

PubMed publication ID

15014630

1 reference

PMC publication ID

181142